PATENT CLAIM ANALYSIS

Application Number: 16124497
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["514", "255030"]

Abstract:
The invention provides new therapeutic uses of 1-[2-(2,4-dimethyl-phenylsulfanyl)phenyl]-piperazine and pharmaceutically acceptable salts thereof.

Claim (Index 10):
A method for the treatment of a CNS disease in a patient in need thereof who has previously received medication (or is still receiving it) for the treatment of said disease which medication was ceased (or has to be ceased) due to weight related adverse events, the method comprising the administration of a therapeutically effective amount of 1-[2-(2,4-dimethyl-phenylsulfanyl)phenyl]piperazine and pharmaceutically acceptable salts thereof to said patient.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 97.0
- Lexical Diversity: 1.0
- Patent Class: 514.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['12741780', '15043167', '15315182', '14767350', '14649087']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7376699594771706
- 35 USC 102 Novelty (BERT): 0.4793908569949278
- Combined Prediction Score: 0.7118420492289463
- Mean Citation Score: 211.074214
- Max Citation Score: 229.31255
- Similarity Product: 197.287100785628

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test